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Background
Monoclonal antibodies have been established as important
therapeutics in cancer and autoimmune diseases. Hence,
there is a growing interest in the production of monoclo-
nal antibodies in pharmaceutical industry. In order to
reduce timelines and costs of production the process and
medium development is of central importance.
Perfusion processes are well known to achieve higher
productivities compared with batch or fed batch. Major
advantages of perfusion culture are that you can keep opti-
mal culture medium conditions for the cells and realize
higher performance. However, obtaining high performance
requires the combination of process optimization as well
as a well-balanced concentrated culture medium. Selecting
the best system also depends on the shear sensitivity of
the cell line, the robustness of the process and the scale
used.
In upstream processing batch, fed batch and perfusion
mode were applied. Design of Experiments (DoE) was
used to develop a feed protocol for fed batch cultivations.
In shake flask experiments the influence of temperature,
osmolality, and pH to improve antibody yield was
examined.
In a further study we compared different cell retention
systems with regard to achieve high viable cell densities
in a short time like required for a seed train application.
The best results were achieved with the ATF system
with cell densities up to 1.3 × 108 cells/ml and 4 fold
improved product concentration compared to batch
culture.
Materials and methods
A CHO cell line producing the antibody G8.8 against
Epithelial Cell Adhesion Molecule (Ep-CAM) was
employed for the experiments performed in this study.
The fermenters were Sartorius BBI Twin-System (2- and
5 L culture volume). We compared five different retention
systems: SpinFilter (Sartorius BBI Systems), Cell Settler
(Biotechnology Solutions), Centritech Lab III (Pneumatic
Scale), Biosep (Applikon) and ATF (Alternate Tangential
Flow; Refine Technology). The cell count was performed
with CEDEX cell counter (Roche Diagnostics). The mono-
clonal antibody was quantified with HPLC-method using
Protein A-column. Design of Experiments (DoE) was used
to develop a feed protocol for Perfusion cultivations. In
shake flask experiments we examined the influence of
temperature, osmolality, and pH to improve antibody
yield.
Results
Fed batch development in shake flasks with DoE
For the development of fed batch in shake flasks we used
D-optimal Design with 18 runs. The examined factors
were: Feed volume, time of feed start, time of temperature
shift (33°C) and time of Osmolality shift (450 mOsmol/kg).
The response was maximum antibody titer. The results
show that the optimal feed volume is 15 ml/d. The time
point for feeding start has almost no influence. The tem-
perature shift and osmolality shift have negative influence
(data not shown).
Comparison of cultivations with different retention
systems
We compared five different cell retention systems under
same cultivation conditions. The best results could be
achieved with the ATF system with cell densities up to
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1.3 × 108 cells/ml. The next best retention systems were
the Centrifuge and the Cell Settler with cell densities
reached up to 3 × 107 cells/ml. Using BioSep and Spin-
filter, cell densities up to 2 × 107 cells/ml were obtained
(data not shown). The Spin filter and BioSep showed
break through of cells at cell densities > 2 × 107 cells/
ml. In contrast, the Cell Settler had the advantage of
simplicity and robustness and no moving parts. The
advantage of the centrifuge was the high flexibility con-
cerning the reactor-volume to be perfused. The Spinfil-
ter and BioSep showed the lowest performance.
Comparison of cultivations with ATF
In a study we compared ATF cultivations with 0.2 μm
membrane and with 50 kDa membrane. In cultivations
with the 0.2 μm membrane a maximum cell density
with 6.4 × 107 cells/ml could be achieved compared to a
maximum cell density of 1.3 × 108 cells/ml with the 50
kDa membrane as shown in Figure 1. The increased cell
densities resulted in a higher productivity compared to
the other cell retention systems. Furthermore, the ATF
with 50 kDa retended not only the cells but also the
antibody within the reactor. Therefore, a higher volu-
metric productivity could be achieved with the 50 kDa
membrane. The maximum titer in the reactor with the
50 kDa membrane was 4 fold higher compared with the
0.2 μm membrane.
Viable cell densities (VCD) and product concentra-
tions of the monoclonal antibody (MAB) are shown.
Conclusions
We have demonstrated that perfusion processes have a
higher productivity compared to batch or fed batch pro-
cesses. In our study the best retention system for perfusion
Figure 1 Comparison of cultivations with ATF 0.2 μm and 50 kDa membrane.
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culture was the ATF system compared with SpinFilter,
Cell Settler, Centritech Lab III and Biosep. With the ATF
system we realized cell densities up to 1.3 × 108 cells/ml
and 4 fold improved product concentration compared to
batch culture. Also, the ATF with a 50 kDa membrane
retended not only the cells but also the antibody within
the reactor. Therefore, a higher volumetric productivity
could be achieved with the 50 kDa membrane. In perfu-
sion culture the cells show constant specific productivity
over the whole perfusion phase which shows that the cells
are well fed.
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